Okada H, Doken Y, Ogawa Y, Toguchi H
DDS Research Laboratories, Takeda Chemical Industries, Ltd., Osaka, Japan.
Pharm Res. 1994 Aug;11(8):1143-7. doi: 10.1023/a:1018936815654.
To obtain a three-month release injection of leuprorelin acetate, microspheres were prepared with copoly(DL-lactic/glycolic acid) or poly(DL-lactic acid) (PLA) using an in-water drying method, and drug release was evaluated. The content of water-soluble oligomers in the polymers was found to strongly affect the initial burst, and reducing the content to less than 0.1% was necessary to keep the first-day release below 10%. Drug loading of more than 15% also increased the initial drug release; the acceptable maximum loading was 12%. Elevation of the glass transition temperature of the microspheres was observed with an increase in drug loading. This suggests formation of a rigid structure, possibly with arrangement of the polymer around the drug cores like in a micelle. This structure provides a hydrophobic barrier against diffusion of the hydrophilic peptide, resulting in high trapping efficiency and long-term sustained release dependent on polymer erosion. The microspheres prepared with PLA having a m.w. of 12,000 to 18,000 provided linear sustained release and persistent serum levels of the drug in rats for over 3 months.
为了获得醋酸亮丙瑞林三个月释放的注射剂,采用水相干燥法,用聚(DL-乳酸/乙醇酸)或聚(DL-乳酸)(PLA)制备微球,并对药物释放进行评估。发现聚合物中水溶性低聚物的含量对初始突释有强烈影响,将其含量降低至0.1%以下对于使第一天释放低于10%是必要的。载药量超过15%也会增加初始药物释放;可接受的最大载药量为12%。随着载药量的增加,观察到微球的玻璃化转变温度升高。这表明形成了一种刚性结构,可能是聚合物围绕药物核心排列,类似于胶束。这种结构为亲水性肽的扩散提供了疏水屏障,导致高捕获效率和依赖于聚合物侵蚀的长期持续释放。用分子量为12,000至18,000的PLA制备的微球在大鼠体内提供了线性持续释放和持续三个月以上的药物血清水平。